Lance David Lewis, DO - Medicare Emergency Medicine in Naples, FL

Lance David Lewis, DO is a medicare enrolled "Emergency Medicine" physician in Naples, Florida. His current practice location is 350 7th St N, Naples, Florida. You can reach out to his office (for appointments etc.) via phone at (239) 624-2700.

Lance David Lewis is licensed to practice in Florida (license number OS19767) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1346878006.

Contact Information

Lance David Lewis, DO
350 7th St N,
Naples, FL 34102-5754
(239) 624-2700
Not Available



Physician's Profile

Full NameLance David Lewis
GenderMale
SpecialityEmergency Medicine
Location350 7th St N, Naples, Florida
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1346878006
  • Provider Enumeration Date: 03/30/2020
  • Last Update Date: 07/17/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0446614226
  • Enrollment ID: I20230912003218

Medical Identifiers

Medical identifiers for Lance David Lewis such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346878006NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine OS19767 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Lance David Lewis allows following entities to bill medicare on his behalf.
Entity NameInphynet Contracting Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073556767
PECOS PAC ID: 7416865811
Enrollment ID: O20031105000125

News Archive

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

Neuroscientists use brain lesion network mapping to identify anatomical origins of free will

Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)

Potential treatments for neurofibromatosis

Scientists at the Indiana University School of Medicine are closing in on potential treatments for neurofibromatosis, a genetic disease that afflicts 100,000 Americans with nerve tissue tumors, some of which become cancerous.

Impax Laboratories prices convertible senior notes due 2022 in private offering

Impax Laboratories, Inc. priced $500,000,000 aggregate principal amount of 2.00% convertible senior notes due 2022 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

Read more Medical News

› Verified 5 days ago

Entity NameSouthwest Florida Emergency Management Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780911206
PECOS PAC ID: 0648314393
Enrollment ID: O20100218000201

News Archive

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

Neuroscientists use brain lesion network mapping to identify anatomical origins of free will

Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)

Potential treatments for neurofibromatosis

Scientists at the Indiana University School of Medicine are closing in on potential treatments for neurofibromatosis, a genetic disease that afflicts 100,000 Americans with nerve tissue tumors, some of which become cancerous.

Impax Laboratories prices convertible senior notes due 2022 in private offering

Impax Laboratories, Inc. priced $500,000,000 aggregate principal amount of 2.00% convertible senior notes due 2022 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lance David Lewis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lance David Lewis, DO
17 Davis Blvd Ste 308,
Tampa, FL 33606-3438

Ph: () -
Lance David Lewis, DO
350 7th St N,
Naples, FL 34102-5754

Ph: (239) 624-2700

News Archive

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

Neuroscientists use brain lesion network mapping to identify anatomical origins of free will

Long the domain of philosophy and religion, free will has also been defined by scientists as a combination of two cognitive processes - the desire to act (or volition) and the sense of responsibility for our actions (or agency.)

Potential treatments for neurofibromatosis

Scientists at the Indiana University School of Medicine are closing in on potential treatments for neurofibromatosis, a genetic disease that afflicts 100,000 Americans with nerve tissue tumors, some of which become cancerous.

Impax Laboratories prices convertible senior notes due 2022 in private offering

Impax Laboratories, Inc. priced $500,000,000 aggregate principal amount of 2.00% convertible senior notes due 2022 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

Read more News

› Verified 5 days ago


Emergency Medicine Doctors in Naples, FL

John Wayne Sponaugle, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 350 7th St N, Naples, FL 34102
Phone: 239-436-5000    
Steven Michael Turbiner, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 350 7th St N, Naples, FL 34102
Phone: 239-436-5000    
Dr. Dylan M Caldwell, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 200 Aviation Dr N Ste 9, Naples, FL 34104
Phone: 239-206-8885    Fax: 239-842-1213
Dr. Jon E Lamos, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 7955 Airport Pulling Rd N Ste 102, Naples, FL 34109
Phone: 239-593-3232    
Jack Derovanesian, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 6400 Davis Blvd Ste 103, Naples, FL 34104
Phone: 239-775-2300    
Joseph John Violaris, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 350 7th St N, Naples, FL 34102
Phone: 239-624-2700    
Katherine Margaret Wietecha,
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 11190 Health Park Blvd, Naples, FL 34110
Phone: 239-610-4377    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.